These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37440943)

  • 1. Hepatic Encephalopathy in Cirrhotic Patients With Bacterial Infections: Frequency, Clinical Characteristics, and Prognostic Relevance.
    Guimarães L; Piedade J; Duarte J; Baldin C; Victor L; Costa B; Veiga Z; Alcântara C; Fernandes F; Pereira G
    J Clin Exp Hepatol; 2023; 13(4):559-567. PubMed ID: 37440943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).
    Cordoba J; Ventura-Cots M; Simón-Talero M; Amorós À; Pavesi M; Vilstrup H; Angeli P; Domenicali M; Ginés P; Bernardi M; Arroyo V;
    J Hepatol; 2014 Feb; 60(2):275-81. PubMed ID: 24128414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.
    Sharma P; Sharma BC; Sarin SK
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):526-31. PubMed ID: 20009938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International normalized ratio and Model for End-stage Liver Disease score predict short-term outcome in cirrhotic patients after the resolution of hepatic encephalopathy.
    Hu XP; Gao J
    World J Gastroenterol; 2019 Jul; 25(26):3426-3437. PubMed ID: 31341366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyponatremia and Its Correlation With Hepatic Encephalopathy and Severity of Liver Disease.
    Younas A; Riaz J; Chughtai T; Maqsood H; Saim M; Qazi S; Younus S; Ghaffar U; Khaliq M
    Cureus; 2021 Feb; 13(2):e13175. PubMed ID: 33717720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of rifaximin use in infections and mortality in patients with decompensated cirrhosis and hepatic encephalopathy.
    Idalsoaga F; Robles C; Ortiz A; Corsi O; Fuentes-López E; Díaz LA; Ayares G; Arrese M; Arab JP
    Therap Adv Gastroenterol; 2024; 17():17562848241254267. PubMed ID: 38812703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.
    Lucidi C; Ginanni Corradini S; Abraldes JG; Merli M; Tandon P; Ferri F; Parlati L; Lattanzi B; Poli E; Di Gregorio V; Farcomeni A; Riggio O
    Liver Transpl; 2016 Oct; 22(10):1333-42. PubMed ID: 27434824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyponatremia as a possible mortality factor in cirrhotic patients hospitalised in the Guillermo Almenara Irigoyen State Hospital, 2003- 2005].
    Rafael Valdivia L; Ferrandiz Quiroz J
    Rev Gastroenterol Peru; 2007; 27(1):37-46. PubMed ID: 17431435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-S-100-beta is increased in patients with decompensated cirrhosis admitted to ICU.
    Weiss N; Tripon S; Mallet M; Imbert-Bismut F; Sakka M; Bonnefont-Rousselot D; Sultanik P; Mouri S; Rudler M; Thabut D
    J Intensive Med; 2024 Apr; 4(2):222-230. PubMed ID: 38681783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
    Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
    Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors of cellulitis in cirrhosis and antibiotic prophylaxis in preventing recurrence.
    Hamza RE; Villyoth MP; Peter G; Joseph D; Govindaraju C; Tank DC; Sreesh S; Narayanan P; Vinayakumar KR
    Ann Gastroenterol; 2014; 27(4):374-379. PubMed ID: 25331211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate.
    Caccamo G; Franzè MS; Saffioti F; Pitrone C; Porcari S; Alibrandi A; Filomia R; Mondello P; Cacciola I; Saitta C; Squadrito G; Raimondo G; Maimone S
    Dig Dis Sci; 2022 Jun; 67(6):2655-2665. PubMed ID: 34041650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis.
    Ahluwalia V; Wade JB; Thacker L; Kraft KA; Sterling RK; Stravitz RT; Fuchs M; Bouneva I; Puri P; Luketic V; Sanyal AJ; Gilles H; Heuman DM; Bajaj JS
    J Hepatol; 2013 Sep; 59(3):467-73. PubMed ID: 23665182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With Cirrhosis.
    Tapper EB; Zhao L; Nikirk S; Baki J; Parikh ND; Lok AS; Waljee AK
    Am J Gastroenterol; 2020 Dec; 115(12):2017-2025. PubMed ID: 32773463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Pathophysiological Characteristics of Cirrhotic Patients with Grade 1 and Minimal Hepatic Encephalopathy.
    Thomsen KL; Macnaughtan J; Tritto G; Mookerjee RP; Jalan R
    PLoS One; 2016; 11(1):e0146076. PubMed ID: 26745876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum S100B Levels in Patients with Liver Cirrhosis and Hepatic Encephalopathy.
    Kim MJ; Kim JH; Jung JH; Kim SE; Kim HS; Jang MK; Park SH; Lee MS; Suk KT; Kim DJ; Choi EK; Park JW
    Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Encephalopathy Is Associated With Mortality in Patients With Cirrhosis Independent of Other Extrahepatic Organ Failures.
    Bajaj JS; O'Leary JG; Tandon P; Wong F; Garcia-Tsao G; Kamath PS; Maliakkal B; Biggins SW; Thuluvath PJ; Fallon MB; Subramanian RM; Vargas HE; Lai J; Thacker LR; Reddy KR
    Clin Gastroenterol Hepatol; 2017 Apr; 15(4):565-574.e4. PubMed ID: 27720916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of cognitive impairment in cirrhotic patients with bacterial infections.
    Merli M; Lucidi C; Pentassuglio I; Giannelli V; Giusto M; Di Gregorio V; Pasquale C; Nardelli S; Lattanzi B; Venditti M; Riggio O
    J Hepatol; 2013 Aug; 59(2):243-50. PubMed ID: 23523580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum sodium, model for end-stage liver disease, and a recent invasive procedure are risk factors for severe acute-on-chronic liver failure and death in cirrhotic patients hospitalized with bacterial infection.
    Lopes-Secundo TM; Sevá-Pereira T; Correa BR; Silva NCM; Imbrizi MR; Cunha-Silva M; Soares EC; Almeida JRS
    Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1055-1059. PubMed ID: 29944488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Negative Prognostic Impact of a First Ever Episode of Spontaneous Bacterial Peritonitis in Cirrhosis and Ascites.
    Ra G; Tsien C; Renner EL; Wong FS
    J Clin Gastroenterol; 2015; 49(10):858-65. PubMed ID: 25811112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.